Related content

The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: A debated therapeutic option

By Gadducci Angiolo   Spirito Nicoletta   Baroni Elena   Tana Roberta   Genazzani Andrea Riccardo  

Gynecological Endocrinology, Vol. 25, Iss. 10, 2009-10 ,pp. : 683-691

Informa Healthcare

Access to resources Recommend Favorite

Daytime pulsed dose rate brachytherapy as a new treatment option for previously irradiated patients with recurrent oesophageal cancer

By Harms W   Krempien R   Grehn C   Berns C   Hensley F W   Debus J  

British Journal of Radiology, Vol. 78, Iss. 927, 2005-03 ,pp. : 236-241

British Institute of Radiology

Access to resources Recommend Favorite

Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer

By  

Current Vascular Pharmacology, Vol. 15, Iss. 6, 2017-09 ,pp. : 503-519

Bentham Science Publishers

Access to resources Recommend Favorite

Collagenase clostridium histolyticum: a novel nonsurgical option for the treatment of Peyronie’s disease

By Aliperti Louis A   Trost Landon W   Hellstrom Wayne JG  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 5, 2013-10 ,pp. : 531-540

Future Medicine

Access to resources Recommend Favorite

Gastrointestinal bleeding during anti-angiogenic peptide vaccination in combination with gemcitabine for advanced pancreatic cancer

By Nagayama Hitomi  

Clinical Journal of Gastroenterology, Vol. 3, Iss. 6, 2010-12 ,pp. : 307-317

Springer Publishing Company

Access to resources Recommend Favorite